EDIT vs NUE · rev $32.3M vs P/E 25, rev $7.08B
Editas Medicine Inc (EDIT) versus Nucor Corp (NUE) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Nucor Corp (NUE) is a steel company listed on NYSE.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported NUE revenue for 2024-12-31 was $7.08B. Net income was $345.0M. Revenue was down 4.9% from 2024-09-28 to 2024-12-31. NUE currently screens at market cap $57.53B and trailing P/E 25.1.
EDIT currently screens at market cap $375.2M. NUE currently screens at market cap $57.53B and trailing P/E 25.1.
Not investment advice. Open the EDIT and NUE stock pages for the full models.
Not investment advice.